Company Filing History:
Years Active: 2015
Title: Innovator Qingyan Yan: Advancing Pharmaceutical Research
Introduction
Qingyan Yan is an accomplished inventor based in Shanghai, China. With a focus on pharmaceutical innovations, he has made significant contributions to the field through his research and invention of novel compounds. His work primarily revolves around the inhibition of protein kinases, which play a crucial role in various cellular processes.
Latest Patents
Qingyan Yan holds a patent for "4-substituted-(3-substituted-1H-pyrazole-5-amino)-pyrimidine derivatives having activity of inhibiting protein kinase and use thereof." This patent includes derivatives substituted by urea that are associated with 4-substituted-(3-substituted-1H-pyrazole-5-amino)-pyrimidine-2-amino of a specified formula. The compounds outlined in the patent may selectively regulate or inhibit an information transmission process controlled by natural or variant tyrosine kinases. Additionally, the patent provides methods for the preparation and uses of these compounds, highlighting their potential in therapeutic applications.
Career Highlights
Currently, Qingyan Yan is affiliated with Zhejiang Hisun Pharmaceutical Co., Ltd., a company known for its commitment to innovative drug development and research. His position at this esteemed organization allows him to collaborate with other talented researchers and contribute to the advancement of pharmaceutical solutions.
Collaborations
Throughout his career, Qingyan Yan has worked alongside esteemed colleagues such as Yili Ding and Xuan Yang. Together, they have fostered a dynamic research environment that encourages collaboration and creativity, driving progress in their shared field of pharmaceutical science.
Conclusion
Qingyan Yan's innovative spirit and dedication to research have led to substantial contributions in the field of pharmaceuticals. With his patent and collaborative efforts at Zhejiang Hisun Pharmaceutical Co., Ltd., he continues to push the boundaries of scientific knowledge, making strides in inhibiting protein kinases and exploring new therapeutic possibilities.